This differentiation is important, because TSC2/PKD1 deletion carries the risk of polycystic kidney disease 1, PKD1 (OMIM# 173,900), associated with symptoms other than polycystic kidney disease, namely cerebral aneurysms and valvular heart disease; lesions not associated with TSC. Here, TSC1 is linked to heart valve disorder.